The trial was stopped early because of futility following recommendations from the data monitoring and ethics committee. The primary outcome occurred in 45/106 patients (42.5%) in the simvastatin ...

Due to the characteristic differences of decision makers (DMs), such as growth experience, educational background, social status, and personal beliefs, individual decision information often varies. It ...

The analysis pointed to a Fair Value target of $161.60, suggesting substantial upside potential of 62.4%. The investment thesis proved remarkably accurate as MYRG reached its target price and ...